Related Experiment Videos
Management of subglottic hemangioma
Seth M Pransky1, Cecilia Canto
1Department Pediatric Otolaryngology and Head-Neck Surgery, San Diego Children's Hospital, San Diego, California 92123, USA. spransky@chsd.org
Current Opinion in Otolaryngology & Head and Neck Surgery
|November 19, 2004
Summary
Subglottic hemangioma (SGH) in children presents management challenges. This review examines various treatments, including steroids, laser ablation, and surgery, noting few innovations but highlighting the need for comparative research.
Area of Science:
- Pediatric Otolaryngology
- Congenital Laryngeal Anomalies
- Surgical Innovation
Background:
- Subglottic hemangioma (SGH) is a complex congenital anomaly affecting the pediatric larynx.
- Current management strategies for SGH lack uniformity, with no single ideal treatment modality established.
- Limited recent literature addresses SGH, necessitating a review of existing and emerging therapeutic options.
Purpose of the Study:
- To review the published literature on the management of subglottic hemangioma (SGH).
- To discuss alternative treatment modalities for SGH, including novel surgical tools.
- To present the authors' approach to SGH management utilizing the microdebrider.
Main Methods:
- Comprehensive literature review of SGH treatments.
- Analysis of various interventions including observation, medical therapies, and surgical techniques.
- Evaluation of the microdebrider as a surgical tool in SGH management.
Main Results:
- Observation is suitable for rare SGH cases with minimal airway obstruction.
- Established treatments include systemic/intralesional steroids, CO2/KTP laser ablation, interferon (IFN), and open surgical excision.
- Few technical innovations in SGH management have emerged in the last five years.
Conclusions:
- All reviewed SGH treatment techniques demonstrate some success but carry inherent risks and potential complications.
- The authors identified limited technical innovations in the field over the past five years.
- Further structured research comparing different SGH treatment modalities is essential for optimizing patient care.